• Pharma and Biotech News Roundup: Tax Policy vs Tariffs, FDA Rehiring Travel Staff, and Custom mRNA Sets

  • May 5 2025
  • Duración: 1 m
  • Podcast

Pharma and Biotech News Roundup: Tax Policy vs Tariffs, FDA Rehiring Travel Staff, and Custom mRNA Sets

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Amgen, along with other big pharma companies, is advocating for a "pro-growth tax policy" over tariffs to boost domestic pharmaceutical manufacturing. They are urging the Trump administration to consider tax policy as a better alternative. A report suggests that low-price drug nations are benefiting from US innovation, FDA is rehiring travel staff, and there are concerns about censorship of scientific truths by RFK Jr. Trilink Biotechnologies has introduced custom sets of mRNA for screening studies. Updates include potential additions of obesity drugs to essential medicines list, company buyouts, layoffs in the industry, and upcoming events and job opportunities in the biotech sector.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Pharma and Biotech News Roundup: Tax Policy vs Tariffs, FDA Rehiring Travel Staff, and Custom mRNA Sets

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles